1.Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM: Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974–2013. JAMA 2017, 317(13):1338–1348.
2.Dean DS, Gharib H: Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008, 22(6):901–911.
3.Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M et al: 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016, 26(1):1–133.
4.Ahn HS, Kim HJ, Welch HG: Korea’s thyroid-cancer “epidemic”—screening and overdiagnosis. N Engl J Med 2014, 371(19):1765–1767.
5.Hu Y, Wang H, Chen E, Xu Z, Chen B, Lu G: Candidate microRNAs as biomarkers of thyroid carcinoma: a systematic review, meta-analysis, and experimental validation. Cancer Med 2016, 5(9):2602–14.
6.Nixon AM, Provatopoulou X, Kalogera E, Zografos GN, Gounaris A: Circulating thyroid cancer biomarkers: Current limitations and future prospects. Clin Endocrinol (Oxf) 2017, 87(2):117–126.
7.Makki FM, Taylor SM, Shahnavaz A, Leslie A, Gallant J, Douglas S, Teh E, Trites J, Bullock M, Inglis K et al: Serum biomarkers of papillary thyroid cancer. Journal of Otolaryngology - Head & Neck Surgery 2013, 42(1):16.
8.Griffin N, Faulkner S, Jobling P, Hondermarck H: Targeting neurotrophin signaling in cancer: The renaissance. Pharmacol Res 2018, 135:12–17.
9.Faulkner S, Jobling P, March B, Jiang CC, Hondermarck H: Tumor Neurobiology and the War of Nerves in Cancer. Cancer Discov 2019, 9(6):702–710.
10.Faulkner S, Roselli S, Demont Y, Pundavela J, Choquet G, Leissner P, Oldmeadow C, Attia J, Walker MM, Hondermarck H: ProNGF is a potential diagnostic biomarker for thyroid cancer. Oncotarget 2016, 7:28488–28497.
11.Hondermarck H: Neurotrophins and their receptors in breast cancer. Cytokine Growth Factor Rev 2012, 23(6):357–365.
12.Levi-Montalcini R: The nerve growth factor: thirty-five years later. Biosci Rep 1987, 7(9):681–699.
13.Tomellini E, Touil Y, Lagadec C, Julien S, Ostyn P, Ziental-Gelus N, Meignan S, Lengrand J, Adriaenssens E, Polakowska R et al: Nerve growth factor and proNGF simultaneously promote symmetric self-renewal, quiescence, and epithelial to mesenchymal transition to enlarge the breast cancer stem cell compartment. Stem Cells 2015, 33(2):342–353.
14.Demont Y, Corbet C, Page A, Ataman-Önal Y, Choquet-Kastylevsky G, Fliniaux I, Le Bourhis X, Toillon R-A, Bradshaw RA, Hondermarck H: Pro-nerve Growth Factor Induces Autocrine Stimulation of Breast Cancer Cell Invasion through Tropomyosin-related Kinase A (TrkA) and Sortilin Protein. J Biol Chem 2012, 287(3):1923–1931.
15.Pundavela J, Demont Y, Jobling P, Lincz LF, Roselli S, Thorne RF, Bond D, Bradshaw RA, Walker MM, Hondermarck H: ProNGF correlates with Gleason score and is a potential driver of nerve infiltration in prostate cancer. Am J Pathol 2014, 184(12):3156–3162.
16.Truzzi F, Marconi A, Lotti R, Dallaglio K, French LE, Hempstead BL, Pincelli C: Neurotrophins and their receptors stimulate melanoma cell proliferation and migration. J Invest Dermatol 2008, 128(8):2031–2040.
17.Faulkner S, Jobling P, Rowe CW, Rodrigues Oliveira SM, Roselli S, Thorne RF, Oldmeadow C, Attia J, Jiang CC, Zhang XD et al: Neurotrophin Receptors TrkA, p75(NTR), and Sortilin Are Increased and Targetable in Thyroid Cancer. Am J Pathol 2018, 188(1):229–241.
18.Moon JH, Kim YI, Lim JA, Choi HS, Cho SW, Kim KW, Park HJ, Paeng JC, Park YJ, Yi KH et al: Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results. J Clin Endocrinol Metab 2013, 98(3):1061–1068.
19.Kudo T, Miyauchi A, Ito Y, Takamura Y, Amino N, Hirokawa M: Diagnosis of medullary thyroid carcinoma by calcitonin measurement in fine-needle aspiration biopsy specimens. Thyroid 2007, 17(7):635–638.
20.Biosensis: BEK–2226 Human proNGF Rapid ELISA Kit. . Biosensis Pty Ltd, Adelaide, Australia 2015.
21.Dicou E: High levels of the proNGF peptides LIP1 and LIP2 in the serum and synovial fluid of rheumatoid arthritis patients: evidence for two new cytokines. J Neuroimmunol 2008, 194(1–2):143–146.
22.Mysona BA, Matragoon S, Stephens M, Mohamed IN, Farooq A, Bartasis ML, Fouda AY, Shanab AY, Espinosa-Heidmann DG, El-Remessy AB: Imbalance of the nerve growth factor and its precursor as a potential biomarker for diabetic retinopathy. BioMed Res Int 2015, 2015:571456.
23.Xu X-M, Dong M-X, Feng X, Liu Y, Pan J-X, Jia S-Y, Cao D, Wei Y-D: Decreased serum proNGF concentration in patients with Parkinson’s disease. Neurol Sci 2018, 39(1):91–96.
24.Bigazzi M, Revoltella R, Aand SC, Vigneti E: High level of a nerve growth factor in the serum of a patient with medullary carcinoma of the thyroid gland. Clin Endocrinol (Oxf) 1977, 6(2):105–112.
25.Dicou E, Lee J, Brachet P: Synthesis of Nerve Growth Factor mRNA and Precursor Protein in the Thyroid and Parathyroid Glands of the Rat. Proc Natl Acad Sci U S A 1986, 83(18):7084–7088.
26.Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M et al: Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. J Clin Endocrinol Metab 2007, 92(2):450–455.
27.Black MA, Pope L, Lefebvre FA, Lefebvre YA, Walker P: Thyroid hormones precociously increase nerve growth factor gene expression in the submandibular gland of neonatal mice. Endocrinology 1992, 130(4):2083–2090.
28.Black MA, Lefebvre FA, Pope L, Lefebvre YA, Walker P: Thyroid hormone and androgen regulation of nerve growth factor gene expression in the mouse submandibular gland. Mol Cell Endocrinol 1992, 84(1–2):145–154.
29.Aloe L, Levi-Montalcini R: Comparative studies on testosterone and L-thyroxine effects on the synthesis of nerve growth factor in mouse submaxillary salivary glands. Exp Cell Res 1980, 125(1):15–22.
30.Walker P, Weichsel ME, Jr., Hoath SB, Poland RE, Fisher DA: Effect of thyroxine, testosterone, and corticosterone on nerve growth factor (NGF) and epidermal growth factor (EGF) concentrations in adult female mouse submaxillary gland: Dissociation of NGF and EGF responses. Endocrinology 1981, 109(2):582–587.
31.Walker P, Weil NL, Weichsel Jr ME, Fischer DA: Effect of thyroxine on nerve growth factor concentration in neonatal mouse brain. Life Sci 1981, 28(15–16):1777–1787.
32.Nam JW, Chung JW, Kho HS, Chung SC, Kim YK: Nerve growth factor concentration in human saliva. Oral Dis 2007, 13(2):187–192.